• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    PAX Health Acquires Richardson Psychiatric Associates, Expanding Mental Health Services for Adults, Adolescents, and Families

    4/17/25 8:27:00 AM ET
    $HLNE
    Investment Managers
    Finance
    Get the next $HLNE alert in real time by email

    RED BANK, N.J., April 17, 2025 /PRNewswire/ -- PAX Health, a leading behavioral healthcare company backed by HCAP Partners and funds managed by Hamilton Lane (NASDAQ:HLNE), today announced its acquisition of Richardson Psychiatric Associates, a comprehensive outpatient psychiatric practice serving adults, adolescents, children, and families.

    Brain tree logo (PRNewsfoto/PAX Health)

    This strategic acquisition enhances PAX Health's portfolio of mental health services and expands its geographic footprint in Western Pennsylvania, strengthening the company's ability to deliver high-quality psychiatric care across diverse patient populations.

    "Richardson Psychiatric Associates has established an outstanding reputation for providing personalized mental health treatment in a compassionate environment," said Anthony DeSena, CEO of PAX Health. "Dr. Richardson and his team's expertise in psychiatric evaluations, medication management, and specialized therapeutic approaches adds significant value to our service offerings and aligns perfectly with our mission to improve access to comprehensive behavioral healthcare, further supporting the expansion of our geographic footprint."

    Co-founded by Dr. W. Randolph Richardson and Lisa Richardson, PMHNP-BC, Richardson Psychiatric Associates offers a wide range of services including psychiatric evaluations, medication management, and various evidence-based therapeutic modalities such as Cognitive Behavioral Therapy, Trauma Therapy, Art Therapy, and Grief Therapy. Dr. Richardson has been practicing psychiatry since 1991, while Lisa has worked in psychiatry since 1987, providing psychiatric evaluations and medication management to patients of all ages.

    "We are excited about the partnership and are looking forward to the opportunity to help grow PAX's presence in Pennsylvania," said Dr. W. Randolph Richardson, MD, Co-Founder of Richardson Psychiatric Associates. "We anticipate being able to use our thirty-plus years of knowledge of the Western Pennsylvania market to improve the availability of high-quality mental health services in our area. We are hopeful that we will have a long-term legacy for our practice as we build our partnership with PAX through the coming years."

    "We look forward to continuing the patient-centered and compassionate care we currently provide in conjunction with our new PAX partners, now with a new ability to grow and expand our services to a broader community," added Lisa Richardson, CRNP, Co-Founder of Richardson Psychiatric Associates.

    This acquisition represents another significant step in PAX Health's growth strategy, supported by healthcare-focused private equity firm HCAP Partners and global investment management firm Hamilton Lane. The integration will enhance PAX Health's ability to deliver customized behavioral health solutions while preserving Richardson Psychiatric Associates' established approach to patient care.

    About PAX Health

    PAX Health is a leading behavioral health company dedicated to providing innovative and comprehensive solutions for mental health and well-being. Through strategic integration of best practices and resources, PAX Health delivers tailored solutions for individuals, businesses, and communities seeking comprehensive behavioral health services.

    About Richardson Psychiatric Associates

    Richardson Psychiatric Associates offers outpatient psychiatric treatment for adults, adolescents, children, and families. Co-founded by Dr. W. Randolph Richardson and Lisa Richardson, PMHNP-BC, the practice provides services including psychiatric evaluations, medication management, and various therapeutic approaches in a comfortable, supportive environment.

    Dr. Richardson is Board Certified in Psychiatry by the American Board of Psychiatry and Neurology. He completed his medical school training at Emory University School of Medicine and completed Psychiatry Residency training at the University of Pittsburgh Medical Center. Lisa Richardson holds a master's degree in Psychiatric Mental Health Nursing from the University of Pittsburgh and Post-Master's Certificates for Psychiatric Mental Health Nurse Practitioner from both Drexel and Rush Universities. She is board certified as a Psychiatric Mental Health Nurse Practitioner Across the Lifespan by the American Nurses Credentialing Center.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/pax-health-acquires-richardson-psychiatric-associates-expanding-mental-health-services-for-adults-adolescents-and-families-302431022.html

    SOURCE PAX Health

    Get the next $HLNE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLNE

    DatePrice TargetRatingAnalyst
    5/15/2025Outperform → Perform
    Oppenheimer
    1/21/2025$186.00Perform → Outperform
    Oppenheimer
    1/6/2025$139.00Neutral → Sell
    Goldman
    9/12/2024$156.00Equal Weight
    Wells Fargo
    4/11/2024$115.00Overweight → Neutral
    JP Morgan
    1/11/2024Outperform → Perform
    Oppenheimer
    5/26/2023$87.00Perform → Outperform
    Oppenheimer
    3/15/2023$85.00Neutral → Overweight
    JP Morgan
    More analyst ratings

    $HLNE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hamilton Lane Launches Global Private Secondary Fund

    The global evergreen fund for secondaries investment seeks to offer a diversified portfolio of mature private equity investments positioned for value creation by leveraging the firm's 24+ years of experience in the secondary market and extensive scaleThis launch marks the 10th fund in Hamilton Lane's $12 billion+ AUM evergreen platformLONDON, Sept. 3, 2025 /PRNewswire/ -- Leading private markets investment firm Hamilton Lane (NASDAQ:HLNE) today announced the launch of the Hamilton Lane Global Private Secondary Fund ("HLGPS" or "the Fund"), an evergreen investment vehicle focused on the secondary market. The Fund is available to accredited high-net-worth investors and their advisors, as well

    9/3/25 2:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Announces Pricing of Public Offering of Class A Common Stock

    CONSHOHOCKEN, Pa., Sept. 2, 2025 /PRNewswire/ -- Private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) ("Hamilton Lane") today announced the pricing of an underwritten public offering by Hamilton Lane and a selling stockholder of 528,705 shares of Class A common stock, in the aggregate, for gross proceeds of approximately $77.5 million. The offering is expected to close on September 4, 2025, subject to customary closing conditions. Hamilton Lane intends to use the proceeds from the sale of its shares to settle in cash exchanges of membership units in Hamilton Lane Advisors, L.L.C. held by certain of its members. Hamilton Lane will not receive any proceeds from the s

    9/2/25 7:23:00 PM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Announces Public Offering of Class A Common Stock

    CONSHOHOCKEN, Pa., Sept. 2, 2025 /PRNewswire/ -- Private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) ("Hamilton Lane") today announced that it has commenced an underwritten public offering of 528,705 shares of Class A common stock, in the aggregate, to be sold by Hamilton Lane and a selling stockholder, subject to market and other conditions.  Hamilton Lane intends to use the proceeds from the sale of its shares to settle in cash exchanges of membership units in Hamilton Lane Advisors, L.L.C. held by certain of its members. Hamilton Lane will not receive any proceeds from the sale of shares by the selling stockholder. Accordingly, Hamilton Lane will not retain any

    9/2/25 4:08:00 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hamilton Lane downgraded by Oppenheimer

    Oppenheimer downgraded Hamilton Lane from Outperform to Perform

    5/15/25 8:08:14 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Hamilton Lane from Perform to Outperform and set a new price target of $186.00

    1/21/25 7:49:57 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane downgraded by Goldman with a new price target

    Goldman downgraded Hamilton Lane from Neutral to Sell and set a new price target of $139.00

    1/6/25 8:11:18 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner French River 5 Ltd sold $21,976,500 worth of shares (150,000 units at $146.51), decreasing direct ownership by 31% to 330,015 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    9/8/25 5:42:00 PM ET
    $HLNE
    Investment Managers
    Finance

    Executive Co-Chairman Rogers Hartley R. disposed of $150 worth of Class B Common Stock (149,875 units at $0.00) (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    9/8/25 5:32:36 PM ET
    $HLNE
    Investment Managers
    Finance

    Large owner Hla Investments Llc disposed of $470 worth of Class B Common Stock (469,880 units at $0.00) (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    9/8/25 5:31:05 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Chief Executive Officer Delgado-Moreira Juan bought $105,950 worth of shares (525 units at $201.81) (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    11/13/24 4:31:06 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    SEC Filings

    View All

    Hamilton Lane Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Hamilton Lane INC (0001433642) (Filer)

    9/5/25 4:29:27 PM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Hamilton Lane INC (0001433642) (Filer)

    9/4/25 4:16:11 PM ET
    $HLNE
    Investment Managers
    Finance

    SEC Form 424B5 filed by Hamilton Lane Incorporated

    424B5 - Hamilton Lane INC (0001433642) (Filer)

    9/3/25 4:15:40 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Leadership Updates

    Live Leadership Updates

    View All

    $HLNE
    Financials

    Live finance-specific insights

    View All

    $HLNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs

    -- Experienced Industry Leader to drive Cosette's Best-in-Class Quality Organization and facilitate Regulatory Approvals -- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has appointed Jeff Neubig as Vice President, Quality and Regulatory Affairs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630266171/en/Jeff Neubig, VP, Quality & Regulatory Affairs, Cosette Pharmaceuticals In this critical role, Jeff will lead Cosette's best-in-class quality and regulatory affairs organizations, maintaining the company's rigorous quality standards and further establishing Co

    6/30/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

    Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I

    4/23/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations

    Industry leader with 35+ years of experience in manufacturing operations and global supply chain excellence Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Vincent (Vin) Colicchio as Senior Vice President of Operations, effective February 3, 2025. In this role, Vin will lead Cosette's manufacturing, global supply chain, and operational strategy, ensuring efficiency, and supply continuity as the company continues its strong trajectory of growth and transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210366017/en/Senior Vice President, Operations (Photo

    2/10/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    HAMILTON LANE INCORPORATED REPORTS FIRST QUARTER FISCAL 2026 RESULTS

    CONSHOHOCKEN, Pa., Aug. 5, 2025 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the first fiscal quarter ended June 30, 2025. The Company issued a full detailed presentation of its first quarter fiscal 2026 results, which can be accessed on the Company's Shareholders website at https://shareholders.hamiltonlane.com/ Dividend Hamilton Lane has declared a quarterly dividend of $0.54 per share of Class A common stock to record holders at the close of business on September 19, 2025 that will be paid on October 6, 2025. The target full-year dividend of $2.16 represents a 10% increase from the prior fiscal year

    8/5/25 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated to Announce First Quarter Fiscal 2026 Results on August 5, 2025

    CONSHOHOCKEN, Pa., July 15, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the first fiscal quarter ended June 30, 2025 before the market opens on Tuesday, August 5, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on August 5 to discuss the results for the first fiscal quarter. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://shareholders.hamiltonlane.com/) at least 15 minut

    7/15/25 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    HAMILTON LANE INCORPORATED REPORTS STRONG FOURTH FISCAL QUARTER AND FISCAL YEAR 2025 RESULTS, WITH MANAGEMENT AND ADVISORY FEES GROWING BY 14% AND ASSETS UNDER MANAGEMENT GROWING BY 11% YEAR-OVER-YEAR

    CONSHOHOCKEN, Pa., May 29, 2025 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the fourth fiscal quarter and full fiscal year ended March 31, 2025. FISCAL YEAR 2025 HIGHLIGHTS Assets under management – Total assets under management of $138 billion grew 11% year-over-year. Fee-earning assets under management increased 10% to $72 billion over the same period.Revenue – Management and advisory fees increased 14% to $513.9 million for fiscal 2025.Carried Interest – Unrealized carried interest balance of $1.3 billion was up 3% year-over-year.Earnings per share – GAAP EPS of $5.41 on $217.4 million of GAAP net i

    5/29/25 7:08:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/13/24 9:56:40 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/12/24 3:55:46 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/4/24 11:53:29 AM ET
    $HLNE
    Investment Managers
    Finance